About
Bio
Impact Factor:
6.198
Journal Ranking:
13/133 in Endocrinology & Metabolism (ISI Journal Citation Reports © Ranking: 2015)
Circulation:
The Publisher does not disclose the circulation.
Aims of the journal:
Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems.
Content:
The journal invites review articles that are balanced, comprehensive and provide new and/or critical analysis of any aspect of drug therapy (or non-pharmacological intervention) relevant to patients with diabetes, obesity or metabolic disorders. The journal will also consider publication of letters to the editor commenting on research already published in the journal, as well as manuscripts describing new hypotheses or clinical trial protocols.
Readership:
Diabetologists; Endocrinologists; Researchers and clinicians working on obesity; Nutritionists; Dieticians; Cardiologists; Podiatrists; Diabetes Educators; Diabetic Specialist Nurses
Editorial contacts:
Editorial contacts:
The editorial office can be contacted at susan.lane@nottingham.ac.uk
Manuscript submission:
Instructions for authors can be viewed here
Online submission can be found here
Email
email@cision.one
Website
site@cision.one
Social media
Location
United Kingdom
Frequency
upgrade
Circulation
upgrade
Sectors
Diabetes
Bio
Impact Factor: 6.198 Journal Ranking: 13/133 in Endocrinology & Metabolism (ISI Journal Citation Reports © Ranking: 2015) Circulation: The Publisher does not disclose the circulation. Aims of the journal: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. Content: The journal invites review articles that are balanced, comprehensive and provide new and/or critical analysis of any aspect of drug therapy (or non-pharmacological intervention) relevant to patients with diabetes, obesity or metabolic disorders. The journal will also consider publication of letters to the editor commenting on research already published in the journal, as well as manuscripts describing new hypotheses or clinical trial protocols. Readership: Diabetologists; Endocrinologists; Researchers and clinicians working on obesity; Nutritionists; Dieticians; Cardiologists; Podiatrists; Diabetes Educators; Diabetic Specialist Nurses Editorial contacts: Editorial contacts: The editorial office can be contacted at susan.lane@nottingham.ac.uk Manuscript submission: Instructions for authors can be viewed here Online submission can be found here
Website
Social media
Location
Frequency
Circulation
Sectors
Diabetes
Most recent articles by Diabetes, Obesity and Metabolism
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to Diabetes, Obesity and Metabolism
-
Medical News Today
Background and Format: Launched in 2003, Medical News Today is a website overseen by Healthline Media UK Ltd and is aimed at healthcare professionals and consumers. Covers health news, diseases, nutrition & diet and pain & aesthetics. For more information about advertising rates, the team can be reached here. Circulation: Source: Publisher.
ViewCChain Drug ReviewEstablished in 1978 and designed for management of chain drug stores, food-drug combination stores, major wholesalers and manufacturers. Provides timely industry news and in-depth product category analysis. Also publishes in-depth features on health and beauty care categories, general merchandise categories, consumables and retail technology. Regular topics include skin care, first aid, hair care, sun care, foot care, beauty products, diabetes, healthcare appliances, smoking cessation and sports medicine. Includes annual supplements, such as the Teen Supplement, which discusses topics affecting teenagers today and the Skin Care supplement, which covers new trends in skin care products. The Annual RX report, The Top 100 Chain Drug Markets listing, the Annual Wholesale Drug Study, the Small Chain Report and the Annual Sales Survey are also included. Press releases and all inquiries should be sent to Vice President/Editorial Director
ViewEating WellDiabetic Living lets you take control and celebrate a healthy lifestyle. Get plenty of recipes, exercise tips, and health guides from a knowledgeable team of experts. The magazine ceased its print publishing in early 2022 and has become an online-only destination.
ViewDDiabetes Technology & TherapeuticsWritten to provide practical information for clinicians; promotes communication between developers and users of new technology and products, and covers the interface between clinical practice, industry, and government.
ViewUse CisionOne to find more relevant outletsExplore journalists that write for Diabetes, Obesity and Metabolism
-
R
Contact us to find more relevant journalistsContact Diabetes, Obesity and Metabolism and get access to over 850K accurate, up-to-date media profiles.
Discover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.